News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,603 Results
Type
Article (8016)
Company Profile (140)
Press Release (476446)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238192)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10374)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3639)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47862)
Collaboration (1242)
Commercialization (3)
Compensation (1465)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5642)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (343)
Diagnostics (4183)
Digital health (38)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73705)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87596)
Executive appointments (702)
FDA (12383)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (917)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (289)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9315)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (16)
Lung cancer (508)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (532)
Marketing (8)
MASH (118)
Medical device (8654)
Medtech (8796)
Mergers & acquisitions (14382)
Metabolic disorders (706)
mRNA (54)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1821)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (171)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (473)
Patient recruitment (506)
Peanut (31)
People (41231)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15464)
Phase 2 (21374)
Phase 3 (14399)
Pipeline (7297)
Policy (18)
Postmarket research (1571)
Preclinical (6538)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (570)
Real estate (3019)
Recruiting (6)
Regulatory (14811)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (320)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (40)
Last 7 days (336)
Last 30 days (1678)
Last 365 days (19083)
2026 (12238)
2025 (19252)
2024 (22988)
2023 (26538)
2022 (34587)
2021 (37167)
2020 (33470)
2019 (23257)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18138)
2012 (20222)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (302)
Arkansas (11)
Asia (17881)
Australia (2098)
California (11949)
Canada (3136)
China (519)
Colorado (482)
Connecticut (409)
Delaware (208)
Europe (24622)
Florida (1788)
Georgia (379)
Hawaii (3)
Idaho (46)
Illinois (699)
India (50)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1201)
Massachusetts (7845)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (115)
New Hampshire (60)
New Jersey (2622)
New Mexico (12)
New York (2822)
North Carolina (1275)
North Dakota (4)
Northern California (5986)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2248)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4961)
Tennessee (119)
Texas (1934)
United States (38818)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (926)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,603 Results for "clinilabs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clinilabs Announces Medical Leadership Appointments
August 5, 2026
·
3 min read
Press Releases
Clinilabs Announces New Affiliation With Rutgers University
June 25, 2026
·
3 min read
Press Releases
Clinilabs Announces Leadership Expansion and Welcomes Laura Shannon as Chief Executive Officer and Promotion of Founder Gary Zammit, Ph.D., to Executive Chairperson
August 13, 2026
·
4 min read
Press Releases
Routine FDA Inspection Completed Successfully With No Findings for Clinilabs
April 15, 2026
·
1 min read
Press Releases
Clinilabs Establishes EU Headquarters in Basel, Strengthening European Clinical Operations Under New Regional Leadership
February 25, 2026
·
2 min read
Press Releases
InTandem Capital Partners Announces Strategic Investment in Clinilabs
March 12, 2025
·
4 min read
Drug Development
Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, announced today that enrollment has begun in a Phase 1/2a clinical trial of CYB003, the first novel psilocybin analog to be evaluated in Phase 1/2a development for the treatment of major depressive disorder (“MDD”).
July 12, 2022
·
8 min read
Business
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
Cybin Inc. and Clinilabs Drug Development Corporation today announced that the U.S. Drug Enforcement Agency (“DEA”) has granted a Schedule I license to support the first-in-human Phase 1/2a clinical trial of CYB003, a proprietary deuterated psilocybin analog that is being developed for the treatment of major depressive disorder (“MDD”).
August 17, 2022
·
8 min read
Business
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
Cybin Inc. today announced that it has partnered with Clinilabs Drug Development Corporation to carry out the Company’s Phase 1/2a clinical trial of CYB003, a proprietary deuterated psilocybin analog.
April 21, 2022
·
7 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
1 of 48,461
Next
